PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.75
Bid: 4.00
Ask: 5.50
Change: -0.25 (-5.00%)
Spread: 1.50 (37.50%)
Open: 5.00
High: 5.00
Low: 4.75
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Follow-on Investment

12 May 2009 07:00

RNS Number : 0702S
Braveheart Investment Group plc
12 May 2009
 



12 May 2009

Braveheart Investment Group plc

('Braveheart' or 'the Group')

Follow-on Investment in Elonics Limited

Braveheart (AIM: BRH), the technology commercialisation and investment management company, announces that it has made a follow on investment into Elonics Ltd. Investors in the £750k funding round included Braveheart and its clients, the Scottish Venture Fund and private investors Sir Tom Farmer and Brian Souter.

Founded in 2003 and based in Livingston, Elonics is the developer of DigitalTuneTM; a flexible radio tuner chip technology platform which can be easily configured to support worldwide industry standards for a wide number of consumer electronics applications. Initial applications include supporting digital TV and radio on both fixed and portable devices.

Early customer feedback for Elonics' first product, the E4000 radio frequency TV tuner, has been encouraging and first customer shipments are expected to be released later this year. The company recently opened an office in Taiwan to service the greater China region.

The market for flexible tuner chips used in mobile devices and home consumer electronics is predicted to grow rapidly over the next few years and Elonics' experienced team and expanding product range means it is well-placed to capitalise on this growth. 

Commenting, Chief Executive of Braveheart, Geoffrey Thomson, said, "Elonics has a differentiating product in terms of cost, power and performance, and one which has real potential to satisfy market need. We are pleased to participate in this follow on round which will enable the company to further progress the E4000's journey to market."

David Srodsinski, Chief Executive of Elonics added "It is a privilege to have the continued support of our investors, particularly in the current environment. Their commitment reflects the strong position Elonics is now in to move forward and grow."

For further information please visit www.braveheart-ventures.co.uk and www.elonics.com or contact:

Braveheart Investment Group

Tavistock Communications (for Braveheart)

Geoffrey Thomson, Chief Executive

Simon Hudson / James Midmer

Tel: 01738 587555

Tel: 020 7920 3150

gthomson@braveheart-ventures.co.uk

shudson@tavistock.co.uk 

Elonics Limited

Seymour Pierce Limited 

David Srodzinski, Chief Executive

(Nominated Advisers to Braveheart)

Tel: 01506 402360 

Richard Feigen/Catherine Leftley

david.srodzinski@elonics.com 

Tel: 020 7107 8000

Notes to Editors

Braveheart

Braveheart Investment Group is a technology commercialisation and investment management company based in Perth, Scotland. Since its formation in 1997 it has made the transition from start-up angel syndicate to fully listed company. Braveheart's shares listed on AIM in March 2007.

Investments are made in young, emerging, unlisted companies where there is potential for significant growth through successful commercialisation of IP and Braveheart enjoys close relationships with several universities to identify emerging technologies. Investments are predominantly technology-focused; however the Group also maintains limited exposure to more traditional businesses.

Braveheart's diverse portfolio currently comprises over 30 companies and it has completed over 80 deals in its eleven year history, including six IPOs, three trade sales and eight write-offs and has an exit IRR of 33%.

At the 2008 Ernst & Young Entrepreneur of The Year Awards (Scotland) Braveheart CEO Geoffrey Thomson was given a special award recognising his contribution and support of emerging technology businesses in Scotland over the past decade.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCABMPTMMTBBML
Date   Source Headline
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
4th Nov 20208:52 amRNSExercise of Warrants and Issue of Equity
3rd Nov 202011:06 amRNSSecond Price Monitoring Extn
3rd Nov 202011:00 amRNSPrice Monitoring Extension
2nd Nov 20202:06 pmRNSSecond Price Monitoring Extn
2nd Nov 20202:01 pmRNSPrice Monitoring Extension
29th Oct 20204:40 pmRNSSecond Price Monitoring Extn
29th Oct 20204:35 pmRNSPrice Monitoring Extension
29th Oct 20207:00 amRNSIssue of shares to certain directors and TVR
27th Oct 20202:05 pmRNSSecond Price Monitoring Extn
27th Oct 20202:00 pmRNSPrice Monitoring Extension
23rd Oct 20207:00 amRNSUpdate on Pharm2Farm’s COVID-19 mask project
19th Oct 20202:06 pmRNSSecond Price Monitoring Extn
19th Oct 20202:00 pmRNSPrice Monitoring Extension
19th Oct 202012:42 pmRNSFurther re. Conditional Sale of Pharm2Farm holding
19th Oct 202012:35 pmRNSPublication of Circular and Notice of GM
16th Oct 20207:00 amRNSFurther update re Paraytec Limited
8th Oct 20204:09 pmRNSUpdate on Pharm2Farm
5th Oct 202011:20 amRNSFurther update re Paraytec Limited
29th Sep 20204:40 pmRNSSecond Price Monitoring Extn
29th Sep 20204:35 pmRNSPrice Monitoring Extension
24th Sep 20207:00 amRNSUpdate on Phasefocus Holdings Limited
18th Sep 20207:00 amRNSUpdate on the Pharm2Farm anti-viral mask project
8th Sep 202012:18 pmRNSResult of AGM
3rd Sep 20207:00 amRNSFurther re Paraytec Limited
28th Aug 20205:00 pmRNSTotal Voting Rights
21st Aug 20205:09 pmRNSConditional Sale of Pharm 2 Farm Limited holding
20th Aug 20201:04 pmRNSHolding(s) in Company
5th Aug 20204:41 pmRNSSecond Price Monitoring Extn
5th Aug 20204:35 pmRNSPrice Monitoring Extension
5th Aug 20207:00 amRNSFurther re Paraytec Limited
4th Aug 20207:00 amRNSFinal Results
23rd Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 20204:41 pmRNSSecond Price Monitoring Extn
21st Jul 20204:36 pmRNSPrice Monitoring Extension
13th Jul 20207:18 amRNSParticipation in RMS placing
7th Jul 20207:00 amRNSFurther re Paraytec Limited
1st Jul 20202:31 pmRNSHolding(s) in Company
30th Jun 20205:00 pmRNSTotal Voting Rights
30th Jun 20203:00 pmRNSAcquisition of 18.1% interest in RMS
19th Jun 20202:29 pmRNSOperational Update
9th Jun 20207:00 amRNSFurther re Paraytec Limited
8th Jun 20207:00 amRNSHolding(s) in Company
5th Jun 202012:44 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSAcquisition of Additional PhaseFocus Shares
3rd Jun 20209:05 amRNSSecond Price Monitoring Extn
3rd Jun 20209:00 amRNSPrice Monitoring Extension
3rd Jun 20207:00 amRNSDirector/PDMR Shareholding
2nd Jun 20204:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.